20 results on '"Eisenhauer, Elizabeth A."'
Search Results
2. Phase II trial of DNA methyltransferase 1 inhibition with the antisense oligonucleotide MG98 in patients with metastatic renal carcinoma: A National Cancer Institute of Canada Clinical Trials Group investigational new drug study
3. Phase II Study of Perifosine in Previously Untreated Patients with Metastatic Melanoma
4. Phase II Trial of SarCNU in Malignant Glioma: Unexpected Pulmonary Toxicity with a Novel Nitrosourea: A phase II trial of the national cancer institute of canada clinical trials group
5. Phase II trial of flavopiridol, a cyclin dependent kinase inhibitor, in untreated metastatic malignant melanoma
6. Phase I and Pharmacokinetic Study of Fostriecin given as an Intravenous Bolus Daily for Five Consecutive Days
7. A phase II study of topotecan in patients with anaplastic oligodendroglioma or anaplastic mixed oligoastrocytoma
8. Phase I and Pharmacologic Study of the Human DNA Methyltransferase Antisense Oligodeoxynucleotide MG98 given as a 21-day Continuous Infusion Every 4 Weeks
9. Phase II Study of Marimastat (BB-2516) in Malignant Melanoma – A Clinical and Tumor Biopsy Study of the National Cancer Institute of Canada Clinical Trials Group
10. Phase I pharmacokinetic study of DUP-937, a new anthrapyrazole
11. Activity of intravenous menogaril in patients with previously untreated metastatic breast cancer: A National Cancer Institute of Canada Clinical Trials Group study
12. Phase II study of docetaxel (taxotere) in patients with previously untreated extensive small cell lung cancer: A trial of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG)
13. Phase II study of elsamitrucin in non-small cell lung cancer
14. Phase II study of 2′-deoxycoformycin in patients with renal cell carcinoma: A National Cancer Institute of Canada Clinical Trials Group study
15. Phase II study of trimetrexate in malignant melanoma: A National Cancer Institute of Canada Clinical Trials Group Study
16. Phase II study of acivicin as a 72-hr continuous infusion in patients with untreated colorectal cancer. A National Cancer Institute of Canada clinical trials group study
17. A phase II study of spirogermanium as second line therapy in patients with poor prognosis lymphoma: An NCI Canada Clinical Trials Group study
18. Phase II study of flutamide in patients with metastatic breast cancer. A National Cancer Institute of Canada Clinical Trials Group study
19. A phase II study of spirogermanium in patients with metastatic malignant melanoma: An NCI Canada Clinical Trials Group study
20. A phase II study of VP-16 and cisplatin in patients with unresectable malignant mesothelioma: An NCI Canada Clinical Trials Group study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.